DEERFIELD, Ill. / Sep 26, 2025 / Business Wire / Baxter International Inc. (NYSE:BAX), a leading global medtech company, today announced that it has been awarded a Gold Level Resiliency Badge from the Healthcare Industry Resilience Collaborative (HIRC) in the categories of IV Solutions, Nutrition Solutions and Premix Drugs. Baxter is the first manufacturer to earn this distinction across these categories, underscoring Baxter’s commitment to building a stronger, more reliable supply chain.
“The HIRC Resiliency Badge is a testament to our team’s relentless focus on helping ensure patients and customers can count on Baxter, no matter the challenge,” said Jim Borzi, Baxter’s executive vice president and chief supply chain officer. “From continuous investments in manufacturing to transformative digital tools, resiliency is built into everything we do. We’re honored to receive this significant industry award that helps validate our ongoing commitment to building a stronger, more transparent supply chain and reaffirms our Mission to Save and Sustain Lives.”
HIRC is a U.S. non-profit healthcare supply chain trade association founded in 2019 by providers and their trading partners to increase resiliency and transparency. The organization sets standards and shares best practices, working as a community of providers, suppliers and industry partners to build a more reliable supply chain. HIRC’s Resiliency Badge is the industry’s first transparent tool to identify high-reliability suppliers, awarded through evidence-based multi-layer assessments at the product category level.
Baxter’s recognition follows HIRC’s comprehensive and rigorous review of the company’s resiliency practices across demand planning, logistics, supplier partnerships and other facets of the supply chain. Baxter was recognized for strength in the following areas:
"The HIRC Resiliency Badge is not about immunity to disruptions, but rather a supplier's level of operational and risk management maturity to better predict, prevent, and recover from supply disruptions,” said Jesse Schafer, HIRC’s executive director. “Through this achievement, in which the company is evaluated on business continuity and operational competence, Baxter demonstrates its commitment and capability in resiliency."
The Gold Level Resiliency Badge builds on Baxter’s ongoing commitment to resiliency, including receiving HIRC’s Transparency Badge in 2023 and 2024, which speaks to a supplier’s efforts to enhance visibility, risk management and business continuity planning. These accolades demonstrate the recipient’s ability to withstand disruptions and help support the availability of critical supplies to the clinicians and patients who rely on them.
About Baxter
At Baxter, we are everywhere healthcare happens – and everywhere it is going, with essential solutions in the hospital, physician’s office and other sites of care. For nearly a century, our customers have counted on us as a vital and trusted partner. And every day, millions of patients and healthcare providers rely on our unmatched portfolio of connected solutions, medical devices, and advanced injectable technologies. Approximately 38,000 Baxter team members live our enduring Mission: to Save and Sustain Lives. Together, we are redefining how care is delivered to make a greater impact today, tomorrow, and beyond. To learn more, visit www.baxter.com and follow us on X, LinkedIn and Facebook.
This release includes forward-looking statements concerning potential benefits associated with the various supply chain and other initiatives and actions included in this release. The statements are based on assumptions about many important factors, including the following, which could cause actual results to differ materially from those in the forward-looking statements: inability to create additional production capacity in a timely manner or the occurrence of other manufacturing or supply difficulties (including as a result of natural disasters, public health crises and epidemics/pandemics, regulatory actions or otherwise); challenges with accurately predicting changing customer preferences and future expenditures and inventory levels; breaches and breakdowns affecting the company's information technology systems or protected information, including by cyber-attack, data leakage, unauthorized access or theft, or failures of or vulnerabilities in the company's information technology systems or products; and other risks identified in Baxter's most recent filing on Form 10-K and Form 10-Q and other SEC filings, all of which are available on Baxter's website. Baxter does not undertake to update its forward-looking statements.
Baxter is a registered trademark of Baxter International Inc. or its subsidiaries.
Last Trade: | US$23.36 |
Daily Change: | 0.59 2.59 |
Daily Volume: | 3,860,956 |
Market Cap: | US$12.000B |
September 16, 2025 July 31, 2025 July 07, 2025 May 01, 2025 |
Compass Therapeutics is a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases. The company's scientific focus is on the relationship between angiogenesis, the immune system, and tumor growth...
CLICK TO LEARN MOREClearPoint Neuro is a global therapy-enabling platform company providing stereotactic navigation and delivery to the brain. Applications of our ClearPoint Neuro Navigation System include electrode lead placement, placement of catheters, and biopsy. The platform has FDA clearance and is...
CLICK TO LEARN MOREEnd of content
No more pages to load